openPR Logo
Press release

Endoluminal Suturing Devices Market worth $139 million by 2027

08-13-2024 08:02 PM CET | Health & Medicine

Press release from: ABNewswire

Asia Pacific is expected to witness the highest growth during the forecast period due to presence of high-growth markets such as India, China, and Japan, the rising cases of gastrointestinal cancer is the major factors that is expected to drive the growth

Asia Pacific is expected to witness the highest growth during the forecast period due to presence of high-growth markets such as India, China, and Japan, the rising cases of gastrointestinal cancer is the major factors that is expected to drive the growth

Endoluminal Suturing Devices Market is projected to grow from USD 78 million in 2022 to USD 139 million by 2027, at a CAGR of 12.0% from 2022 to 2027, according to a new report by MarketsandMarkets Trademark
Endoluminal Suturing Devices Market [https://www.marketsandmarkets.com/Market-Reports/endoluminal-suturing-devices-market-250924884.html?utm_source=ABnewswire&utm_medium=Paid&utm_campaign=Referral] is projected to grow from USD 78 million in 2022 to USD 139 million by 2027, at a CAGR of 12.0% from 2022 to 2027, according to a new report by MarketsandMarkets Trademark . The increasing number of surgical procedures worldwide, the rising prevalence of gastrointestinal diseases along are some of the key factors driving the market for endoluminal suturing devices.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250924884 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250924884&utm_source=ABnewswire&utm_medium=Paid&utm_campaign=Referral]

The gastrointestinal surgery segment to witness the highest growth during the forecast period

Based on application, the endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries. The gastrointestinal surgery segment is expected to register the highest growth during the forecast period. This can be attributed to the growing adoption of endoluminal suturing devices for the growing number of gastrointestinal cancer cases worldwide and the increasing prevalence of gastrointestinal disorders.

The ambulatory care centers segment to witness the highest growth during the forecast period

Based on end users, the endoluminal suturing devices market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The ambulatory care centers segment is expected to register the highest growth during the forecast period. This can be attributed to the cost-effective treatments offered to patients in ambulatory surgery centers.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=250924884 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=250924884&utm_source=ABnewswire&utm_medium=Paid&utm_campaign=Referral]

The Asia Pacific region is expected to witness the highest growth during the forecast period

Asia Pacific is expected to witness the highest growth during the forecast period due to presence of high-growth markets such as India, China, and Japan, the rising cases of gastrointestinal cancer is the major factors that is expected to drive the growth of the endoluminal suturing devices market in the Asia Pacific region.

The prominent players in the endoluminal suturing devices market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=250924884 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=250924884&utm_source=ABnewswire&utm_medium=Paid&utm_campaign=Referral]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=endoluminal-suturing-devices-market-worth-139-million-by-2027]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/endoluminal-suturing-devices-market-worth-139-million-by-2027--exclusive-report-by-marketsandmarkets-301609079.html



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endoluminal Suturing Devices Market worth $139 million by 2027 here

News-ID: 3622269 • Views:

More Releases from ABNewswire

BitX Capital Champions Merchant Cash Advance as a Flexible Funding Alternative for Modern Businesses
BitX Capital Champions Merchant Cash Advance as a Flexible Funding Alternative f …
About BitX Capital: Founded in 2013, BitX Capital specializes in connecting small and medium-sized businesses with customized funding solutions. Leveraging deep market knowledge and led by a veteran team, BitX Capital simplifies the complex world of business lending, empowering businesses with the capital needed for growth and stability. October 9, 2025 - BitX Capital, a trusted leader in small business financing, today announcement underscored the value of the Merchant Cash Advance
Cell and Gene Therapy in Parkinson's Disease Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Prevail Therapeutics (Eli Lilly), MeiraGTx, Hope Biosciences
Cell and Gene Therapy in Parkinson's Disease Market to Experience Notable Growth …
The Key Cell and Gene Therapy in Parkinson's Disease Companies in the market include - Prevail Therapeutics (Eli Lilly), MeiraGTx, Hope Biosciences, and others. DelveInsight's "Cell and Gene Therapy in Parkinson's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cell and Gene Therapy in Parkinson's Disease, historical and forecasted epidemiology as well as the Cell and Gene Therapy in Parkinson's Disease market trends in the
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeu
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others. DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,

All 5 Releases


More Releases for Asia

Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value. https://boomingfaucet.com/ Asia Private Equity Consulting E-mail:nolan@pandacuads.com In China,
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the